Competitor News, HR

Komodo Health Appoints Dr. Aswin Chandrakantan as Chief Operating Officer

Dr. Chandrakantan to Lead Komodo’s Operational Growth and Strategic Expansion Efforts as the Company Scales Across More Than a Dozen Market Segments May 24, 2022 – SAN FRANCISCO: Komodo Health today announced that Dr. Aswin Chandrakantan has been appointed as the company’s first Chief Operating Officer, effective immediately. Dr. Chandrakantan will…

Competitor News

The National COVID Cohort Collaborative (N3C) Privacy-Preserving Record Linkage Powered by Datavant and Regenstrief Wins 2022 FedHealthIT Innovation Award

SAN FRANCISCO, May 24, 2022 (GLOBE NEWSWIRE) — Datavant, the leader in helping organizations securely connect health data today announced that the National COVID Cohort Collaborative Privacy-Preserving Record Linkage (N3C PPRL), powered by Datavant technology and Regenstrief Institute’s Linkage Honest Broker services, has been recognized with a 2022 FedHealthIT Innovation…

Collaborations, Competitor News, Data Partnership, Oncology

UPenn researchers found reduced absorption of Janssen’s Balversa in eligible bladder cancer patients

NEW YORK – It’s been three years since the US Food and Drug Administration agreed Janssen’s Balversa (erdafitinib) for patients with advanced bladder tumors harboring FGFR3 or FGFR2 gene alterations, however a recent analysis showed that uptake of targeted therapy was very low. In a retrospective analysis published last week in gamma tumors,…

Collaborations, Data Partnership, Oncology, Partner and Collaborator News, RWE Study

Patient- And Provider-Level Predictors of Survival Among Patients With Metastatic Renal Cell Carcinoma Initiating Oral Anticancer Agents

ABSTRACT PURPOSE: In an era of rapid expansion of FDA approvals for oral anticancer agents (OAAs), it is important to understand the factors associated with survival among real-world populations, which include groups not well-represented in pivotal clinical trials of OAAs, such as the elderly, racial minorities, and medically complex patients….

Competitor News, RWE Study

New Data Presented at DDW 2022 Shows Nearly Two-Fold Risk of Loss of Remission in Ulcerative Colitis Patients who had Histologic Inflammation on Baseline Biopsy

DURHAM, N.C., May 22, 2022 /PRNewswire/ — New data shows that more than a third (36.6%) of ulcerative colitis (UC) patients who have previously responded to advanced therapies experienced a loss of remission (LOR) in their symptom control, often within a year. The analysis from Target RWE’s TARGET-IBD large, longitudinal cohort, Inflammation on Index Biopsy…

Competitor News, HR

Health Gorilla Hires New Senior Vice President of Product

alo Alto, California, May 20, 2022 (GLOBE NEWSWIRE) — Health Gorilla, a leading Health Information Network and interoperability provider expanding healthcare data access nationwide, announced today that it has brought on Derek Plansky as the new Senior Vice President of Product. Plansky will guide Health Gorilla’s product vision, strategy, design, and development as…